September 21, 2020 — Integral Molecular become awarded over $520,000 from the reveal of Pennsylvania to leverage its technologies in COVID-19 be taught. The grant will enable the firm and its companions to ticket therapies and vaccines in opposition to SARS-CoV-2.
Four of Integral Molecular’s abilities platforms are being worn within the battle in opposition to the virus, including:
- MPS Antibody Discovery platform to generate reactive antibodies in opposition to SARS-CoV-2 and other coronaviruses
- SARS-CoV-2 reporter virus particles (RVPs) to take a look at the protection for neutralizing immune responses in patients and vaccines
- Membrane protein array (MPA) to conceal conceal for specificity of antibodies for SARS-CoV-2
- Shotgun mutagenesis epitope mapping to optimize vaccine and antibody create
The funding become bought by the reveal’s COVID-19 Vaccines, Therapies, and Therapies (CV-VTT) program.
Copyright © 2020 scienceboard.discover